Highlight Capital

Highlight Capital is a venture capital firm based in Shanghai, China, founded in 2014. The firm is dedicated to supporting healthcare companies in achieving strong and sustained growth prospects within the Chinese market. Highlight Capital focuses on investing in various sectors, including healthcare services, biomedicine, medical technology, mobile healthcare, and pharmaceuticals. The firm aims to partner with entrepreneurs who demonstrate commitment and uphold high standards in their endeavors.

Zhao Gang

Founding Partner

87 past transactions

Rgenta Therapeutics

Series A in 2023
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology. Its proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glue to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Its lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. It was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.

Yaotan Pharmaceutical

Series A in 2022
Yaotan Pharmaceutical offers one-stop CDMO services for the research and production of raw materials and preparations CMC, covering the formulation process development, quality research, registration, and declaration of chemical raw materials and preparations, as well as for customers. They adhere to the unique concept and original aim of assisting the globe in the discovery and development of novel drugs. They are committed to establishing a service platform for small-molecule medication research and development.

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

Bichen Pharmaceutical

Series B in 2022
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

SparX Group

Series B in 2021
SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

Thousand Oaks Biopharmaceuticals

Venture Round in 2021
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Qinghui Liannuo

Seed Round in 2021
Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.

Vision X

Series B in 2021
Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.
Diseases do not recognize borders; why should drug innovation? We are a team of scientists and physicians driven by a shared commitment: to fulfill unmet medical needs for patients worldwide by harnessing the most effective resources and efficient processes for drug development. We may take the brainchild of a scientist in one country to conduct proof of concept studies in another, and seamlessly transition to later clinical development globally. We coined our approach “Borderless Innovation.” Focused on immunology and inflammation, we are developing a new generation of drug candidates characterized by prolonged pharmacokinetic and pharmacodynamic effects as well as improved safety margins. This will potentially enable improved efficacy/safety profiles and dosing convenience. Leveraging cutting-edge technology, we have a rich pipeline consisting of four clinical-stage assets, targeting validated pathways, and multiple innovative preclinical candidates.

Chongxing Chongwu

Series B in 2021
Chongxing Chongwu is a supplier of pet supplies.

Hope Medicine

Series B in 2021
Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.

Zonsen Peplib Biotech

Series A in 2021
Zonsen Peplib Biotech builds a peptide compound library and provides peptide drug discovery and development services for global pharmaceutical and biotech companies. The company's technology could compress the amino acid sequence information of about 500,000,000 peptides into 80,000 peptide compounds.

Abogen Biosciences

Series B in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Artivila Therapeutics

Seed Round in 2021
Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform, providing first-in-class new molecules consistently and efficiently. Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.

Biotheus

Series D in 2021
Biotheus is a biotech company that focuses on curing malignant tumors and autoimmune diseases. Biotheus is committed to the research, development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.

Novast

Venture Round in 2021
Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.

Imago BioSciences

Series C in 2020
Imago BioSciences is a clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives. Imago BioSciences was founded in 2012 and is based in Redwood City, California.

XINGYUN GROUP

Series C in 2020
Xingyun Group has reconstructed the digital supply chain in consumer goods. It empowers the global commodity trade environment through whole-process SaaS tools, and provides one-stop, full-category, Direct-to-consumer (DTC) digital supply chain services in consumer goods. The Management Middle-end System Services Engine of Xingyun Global Supply Chain focuses on the integration of industrial ecological resources, enables cost reduction and efficiency improvement with industrial data, serves overseas consumer brands to enter China, helps Chinese brands go global, and empowers global supply chain and SaaS service capability of the platform for massive merchants. It has nearly 160 cooperative and self-operated warehouses in 72 countries and 1 region, serving more than 350,000 online and offline retailers in China.

Gaugene

Series A in 2020
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Soocas

Series C in 2020
Founded in 2015, Soocas (Shenzhen) Technology Co., Ltd. is an Internet technology company dedicating to personal digital product for health care. Based on customers’ requirements, Soocas conducted independent R&D and innovations to persistently devote to providing advanced, intelligent, high-performance and high-quality product and service for personal health care. Currently, its core businesses are Soocas sonic electronic toothbrush and Soocas mobile APP. As a member of Xiaomi’s ecologic chain, Soocas Technology’s members mostly come from famous hardware companies such as Huawei, Oral-B and Philips, which brings Soocas with many years’ experience of product design and R&D in consumer electronics, deep cognition in hardware and significant edges in product design, product experience and UI. Soocas is a sonic electronic toothbrush brand under Soocas Technology. It has many patents in the field and its representing product is X3. Upholding the concept of “Passion, Focus and Excellence”, Soocas is going to forge better products of sonic toothbrush.

Hanyu Medical

Series D in 2020
Hanyu Medical is one of the first domestic companies to develop, produce, and sell transcatheter mitral valve repair devices. At present, the company’s core product is Valve Clamp, a mitral valve interventional device, which is used for minimally invasive interventional treatment of mitral valve regurgitation diseases.

Novast

Venture Round in 2020
Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.

ChosenMed

Series B in 2020
ChosenMed is a healthcare company in oncology precision medicine, focusing on early tumor screening and companion diagnosis.

GenFleet Therapeutics

Series B in 2020
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

4inLook

Venture Round in 2020
4iNLOOK was founded in 2008 and now has more than 300 specialty color contact lens stores nationwide, mainly in shopping centers in first-and second-tier cities. It offers more than 200 color contact lens options with different designs for women aged 18-30. Meanwhile, 4iNLOOK is also opening up online channels, with its Tmall store and national chain stores offering a new retail shopping experience that allows consumers to place orders online, take orders offline, make appointments online, and experience the products offline.

Xinjunte

Series A in 2020
Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

Ennovabio

Series A in 2019
Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.

Genetron Health

Series D in 2019
Genetron Health is a world-leading expert in precision medicine.They are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology diagnosis, medication guidance and prognosis monitoring) and effectively applying genomic data to assist medical experts and research scientists. Additionally, they provide cancer patients and high-risk and healthy individuals with reliable molecular clinical services and professional cancer genetic risk assessment.In just three years, Genetron Health has built global genomics sequencing and bioinformatics platforms, established two research and development centers in both North Carolina, U.S., and Beijing, China, and set up clinical laboratories in Beijing, Shanghai, Hangzhou and Chongqing of over 10,000 square meters.In the future, Genetron Health will spread its sales network throughout China with professional marketing, product management, medical experts and scientific research teams, and will provide service for Chinese and global cancer patients with its strong foundation in cancer genomics and efficient clinical translation.
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Verseau Therapeutics

Venture Round in 2019
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.

Julikang

Series B in 2019
Julikang is a third-party medical device disinfection supply service provider that can interface with hospital information systems (HIS systems) through sterile item traceability management software. After accessing the hospital HIS system, the whole process of traceability management of sterile articles was realized. In addition, Julikang directly accesses the equipment manufacturer interface to the traceability management software, which enables third-party disinfection suppliers to read the physical parameter information of the device in real time. .

Loving Care

Series B in 2019
Loving Care International Pet Hospital is a comprehensive animal medical institution that includes beauty, physical examination, vaccines, clinics, etc., and provides users with prevention information on common dog diseases, common cat diseases, alternative pet diseases, and launches mobile animal service vehicles for pets. Provide home-based basic medical services.

ONLY STEM

Series A in 2019
Angstrom STEM is a brand of Anglia Education Group, integrating the resources and achievements of science and technology education of Shanghai Jiaotong University, and introducing the technology experience model of the United States and Canada, innovatively opening up STEM entertainment and education, integrating scientific experiments, model construction, mechanical energy, robot construction With programming, 3D printing, mathematics, etc., and focusing on the application and innovation of the latest science and technology, we have established a complete scientific STEM curriculum system to promote the quality education of domestic children and build a leading high-end STEM education brand in China.

Bitwise

Series A in 2019
Bitwise is a crypto-specialist asset manager for individuals, investment managers, and institutions navigating cryptocurrency. The company offers a suite of 32 investment solutions, including yield and alpha strategies, multi-strategy solutions, separately managed accounts, onchain staking, index funds, bitcoin ETPs, and more. By serving as a specialist partner, it enables clients to access the opportunities that meet their objectives.

NewDoon

Series B in 2019
NewDoon is a research, development, and manufacturing company of life science products and solutions. It is a company that develops neuroscience products and solutions. They have developed wireless optogenetics systems, fiber photometry systems, and miniaturized fluorescence microscopy.

Cullgen

Series A in 2019
Cullgen is a drug discovery service intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use protein degradation technology that focuses on the selective degradation of disease-causing proteins, a novel treatment for cancer, inflammatory and autoimmune diseases, including targets previously considered undruggable, enabling scientists with new means to develop novel therapeutic approaches for various diseases.

Abiochem Biotechnology

Series A in 2019
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products, pesticides, etc., and has contributed to the promotion and development of green chemistry.

Imago BioSciences

Series B in 2019
Imago BioSciences is a clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives. Imago BioSciences was founded in 2012 and is based in Redwood City, California.

Boholo

Seed Round in 2019
Baolulu Digital Medical Network Platform is an integrated platform for Internet-based digital medicine consisting of Baohulu Digital Medicine Series Software, Baohulu Digital Medicine Network, Baolulu Digital Medical Workstation and Baohulu Mobile Station. It is used to provide treatment for specialists around the world. A comprehensive service platform for software tool assistance, medical platform support, departmental services, and physician professional communication assistance, which is available to all specialists worldwide.

BrightGene

Venture Round in 2019
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

GenFleet Therapeutics

Series A in 2018
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

VCBeat

Series A in 2018
VBData provides brand communication and industry consulting services. They create a service platform for healthcare entrepreneurs, including industry research, media communication, and industry resource integration.

ZQ Automotive

Angel Round in 2018
ZQ Automotive specializes in the field of automotive electronics and human-machine voice interaction technology.

Biotheus

Series A in 2018
Biotheus is a biotech company that focuses on curing malignant tumors and autoimmune diseases. Biotheus is committed to the research, development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.

Maló Clinic

Series D in 2018
MALO CLINIC was established in 1995 by Dr. Paulo Malo. Today is world’s leader in Implantology and Dental Cosmetic as well as an Educational Centre on Oral Rehabilitation that trains over 3,500 professionals coming from all over the world per year. Besides Dentistry MALO CLINIC expanded to other health specialties, projecting an innovative concept of Medical Spa through a strong bet in wellbeing which resulted in the foundation of a Health Management business group spread worldwide known as MALO CLINIC Health & Wellness.
Huidu Medical provides development of gene detection methods and bioinformatics algorithms for cancer diagnosis and monitoring, and promotes the development of tumor diagnosis and treatment through our technology.

Gaugene

Angel Round in 2018
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Chemclin

Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. Chemclin Biotech’s service covers clinical inspection instruments, auxiliary reagents (chemiluminescence, biochemical, exemption), technical services, management and certification, independent medical laboratories, and more. The company is dedicated to the introduction of diagnostic products and services to the Chinese market.

Chowsing Live

Series A in 2018
Chowsing Live is a pet product company that promotes design and creativity. It develops pet products that address the real needs of pets and pet-raising families in order to promote a natural and harmonious lifestyle for pets and owners.

MoonBiotech

Seed Round in 2018
MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

ChosenMed

Series A in 2018
ChosenMed is a healthcare company in oncology precision medicine, focusing on early tumor screening and companion diagnosis.

GenFleet Therapeutics

Seed Round in 2018
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Kunya Medical

Series B in 2018
Kunya Medical Is a medical equipment service platform provider, the company|s main business includes the hospital image, radiation equipment maintenance department hosting service, hospital overall hosting service of medical equipment, professional to provide domestic and foreign brands of large and medium-sized medical equipment Bai Jinbao, Dr. Richard kimble, technical maintenance, equipment moving, installation, debugging and other services, at the same time provide a full range of spare parts and equipment management software.

Junhetang

Series C in 2018
Junhetang is an operator of traditional Chinese medicine clinics. It is a chain of traditional Chinese medicine (TCM) healthcare management and service centers. Junherang has combined TCM culture, rare and renowned TCM experts, personalized medical services and convenient internet services to establish an innovative TCM service network with education, training, medical care, health maintenance and IT service functions. The company operates a chain of clinics that offers traditional Chinese medicines and therapies including herbal medicine, acupuncture, massage, exercise and dietary therapies. Headquartered in Nanjing, an ancient city in China, Junhetang is now expanding its business in different cities in China, such as Nanjing, Shanghai, Shenzhen, Chengdu, Taiyuan and so on.

Chongxing Chongwu

Series A in 2018
Chongxing Chongwu is a supplier of pet supplies.
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Sansure Biotech

Corporate Round in 2018
Sansure Biotech Inc. is a Changsha, Hunan Province-based biotechnology company focusing on molecular diagnosis and genetic testing techniques. It develops and manufactures nucleic acid extraction kits, real time polymerase chain reaction(PCR) diagnostic & research kits and fluorescence systems.

Loving Care

Angel Round in 2017
Loving Care International Pet Hospital is a comprehensive animal medical institution that includes beauty, physical examination, vaccines, clinics, etc., and provides users with prevention information on common dog diseases, common cat diseases, alternative pet diseases, and launches mobile animal service vehicles for pets. Provide home-based basic medical services.

Ennovabio

Seed Round in 2017
Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.

WinnTi Medical

Series B in 2017
WinnTi Medical creates medical devices through continuous product innovations and manufacturing improvements, meeting surgeons' increasing demands, and improving patients' wellness.

GENERAL HEALTHY

Series A in 2017
GENERAL HEALTHY provides pharmaceutical logistics automation and mobile medical solutions.

Xiao Qu Hao Hushi

Series A in 2017
Xiao Qu Hao Hushi provides online medical consultancy services through an application.

RUNDO

Series B in 2017
Rundong Pharmaceutical R&D is a CRO company specializing in drug clinical research outsourcing and providing one-stop service. It is the main initiator and promoter of china CRO Alliance (CROU) and is now CROU. The president unit is the first CRO company in china's CRO industry to pass the ISO 9001:2008 quality management system combined with CRO industry standard certification.

Siyuans Aviation Tech

Angel Round in 2017
Siyuans Aviation Tech is a tech enterprise that integrates mechanical, electrical, control, automation, and development. They develop and sell intelligent maintenance systems for airport navigation lights. They offer fragile parts, integrated cabins, and multi-functional security wells for airport flight areas.
It involves in the development of children''s physical and mental health management platform. Health Management Center Co., Ltd. engages in the provision of mobile internet parenting health guidance online interaction and offline services.

XANTHUS MEDIA

Angel Round in 2016
Xanthus Media is an animation production company. They involve in presenting audio-visual feasts and conveying emotional value. Screenwriting, designing, special effects, strategic consulting, management, and marketing are the business line of this company.

Tellyes Scientific

Post in 2016
Tellyes Scientific is a comprehensive technology enterprise that integrates the research and development, production, and sales of modern medical teaching products. The company engages in innovation, research, and development activities in a number of important fields with training software and a traditional Chinese medicine training system supported by contemporary technology, and offers the market twelve series and more than a thousand different types of medical virtual teaching products based on the aforementioned technologies.
Shanghai Gandong Xin Nengyuan Keji Co. Ltd. provides mobility, R&D and production of software & in-vehicle intelligent hardware solutions.

Kunya Medical

Series A in 2016
Kunya Medical Is a medical equipment service platform provider, the company|s main business includes the hospital image, radiation equipment maintenance department hosting service, hospital overall hosting service of medical equipment, professional to provide domestic and foreign brands of large and medium-sized medical equipment Bai Jinbao, Dr. Richard kimble, technical maintenance, equipment moving, installation, debugging and other services, at the same time provide a full range of spare parts and equipment management software.

Kontour Medical

Series A in 2016
Kontour Medical provides health care equipment services. They offers products that include neurosurgery products, cardiothoracic surgery products, neurospine products, an oral implant system, and other surgical products.

JunHe

Series B in 2016
JunHe is a Chinese independent law firm that provides legal services to clients from Asia and Europe.

Annet Information System

Series B in 2016
Antai Innovation focuses on product innovation in hospitals, Internet hospitals, medical associations, the construction of medical big data systems and the effective landing of artificial intelligence products. Based on the “Annet Heterogeneous Information Integration Platform, Annet Cloud Image Center” with independent intellectual property rights, the company comprehensively pools the medical core medical treatment data of millions of patients, and realizes the interconnection and sharing of panoramic information through mobile internet, cloud image and AI technology. All levels of medical institutions to achieve comprehensive, full-cycle, continuous medical services.

Genechem (China)

Series B in 2016
Jikai Gene Chemical Technology Co., Ltd. is headquartered in Shanghai Zhangjiang Hi-Tech Park, a national high-tech park. It is a high-tech enterprise integrating genetic technology service, research and development, technology transformation, product development, production and sales. .
It involves in the development of children''s physical and mental health management platform. Health Management Center Co., Ltd. engages in the provision of mobile internet parenting health guidance online interaction and offline services.

Baheal Pharmaceutical Group

Angel Round in 2015
Baheal Pharmaceutical Group is a pharmaceutical commercialization platform. They also provide health brand marketing promotion, pharmaceutical wholesale distribution, and retail services.

eDoctor

Series A in 2015
EDoctor is a pharmaceutical digital company. They developed the eDetailing Suite, the Patients Management Project, Live CME, Healthcare Sales Force Efficiency Tools, and other innovations. Their goal is to be a pioneer in increasing pharmaceutical marketing through high-tech solutions.

Zylox

Series A in 2015
Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China. Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.

BDG

Series A in 2015
BDG is a specialist hospital focusing on the diagnosis and treatment of brain diseases, brain health management, and brain neurology research.

Quyi Network

Series B in 2015
Quyi Network is a technology company based in China.

KYEE

Series C in 2015
KYEE is a manufacturer of products and services for the medical cloud business that covers many fields, such as medical cloud, smart ward, and big data in health care. The company's process of deepening medical information technology. KYEE helps medical institutions improve service quality and efficiency, ensuring medical safety effectively.

Suzhou Kintor Pharmaceuticals

Venture Round in 2015
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

WinnTi Medical

Series B in 2015
WinnTi Medical creates medical devices through continuous product innovations and manufacturing improvements, meeting surgeons' increasing demands, and improving patients' wellness.

Oranger

Series A in 2014
Oranger is a developer of portable wearable medical devices, focused on the treatment of medical-grade chronic respiratory diseases such as sleep apnea.

iHear Medical

Series B in 2012
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearing aid. iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR. iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers. iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.